A. Studer et al.
FULL PAPER
2,2,7,7-Tetraethylazepan-4-ol (11): To a solution of azepanone 9 (63 mg,
0.32mmol) in THF (2mL) was added LAH (36 mg, 0.32mmol). The re-
action mixture was stirred at 258C for 12h, then heated to reflux for 4 h.
After the mixture had been cooled to room temperature, water (15 mL),
a 15% aqueous solution of NaOH (15 mL), and water (30 mL) were
added with 5 min intervals with stirring. The suspension was finally al-
lowed to stir for 20 min while a white precipitate formed. Filtration,
washing with MTBE, drying (MgSO4), and evaporation of the solvents in
vacuo yielded the alcohol 11 (57 mg, 78%), which was used without fur-
ther purification. IR (film): n˜ = 3347br, 2966s, 2936s, 2878m, 1461s,
1305m cmꢀ1
;
1H NMR (300 MHz, CDCl3): d = 7.35 7.23 (m, 5H, CH),
4.77 (br, 1H, CH), 2.41 2.27 (m, 4H, CH2), 2.32 (s, 3H, CH3), 2.04 (s,
3H, CH3), 1.49 (d, J = 5.4 Hz, 3H, CH3), 1.31 1.21 (m, 10H), 0.88 ppm
(t, J = 5.6 Hz, 6H, CH3); 13C NMR (75 MHz, CDCl3): d = 209.8 (C),
144.2 (C), 128.1 (2CH), 127.4 (CH), 126.6 (2CH), 83.3 (CH), 65.8 (C),
60.4 (C), 53.1 (CH2), 47.4 (CH2), 33.4 (CH3), 33.3 (CH3), 30.9 (CH2), 28.5
(CH2), 23.5 (CH3), 9.5 (CH3), 8.4 ppm (CH3); MS (ESI): 326 (100,
[M+Na]+), 304 (41, [M+H]+), 242 (53); HRMS (ESI) calcd for
C19H29NNaO2 ([M+Na]+): 326.2096; found: 326.2091.
2,2,7,7-Tetraethyl-1-(1-phenylethoxy)azepan-4-one (16): Nitroxide 10
(200 mg, 0.83 mmol), Cu dust (53 mg, 0.83 mmol), Cu(OTf)2 (15 mg,
0.042mmol), (4,4 ’-di-tert-butyl)-2,2’-bipyridine (23 mg, 0.168 mmol), 1-
phenylethylbromide (154 mg, 0.83 mmol), and benzene (3.0 mL) were
heated for 48 h to 758C in a sealed tube under an argon atmosphere. Fil-
tration over a thin pad of SiO2, washing with MTBE, evaporation of the
solvents in vacuo, and purification by FC (diethyl ether/pentane 1:30)
yielded 16 (64 mg, 22%) as a mixture of two diastereoisomers because of
the chirality at the nitrogen atom (d.r. = 1.1:1). IR (film): n˜ = 3369w,
2963s, 2878s, 1705s, 1462s, 1359m, 1180m cmꢀ1; MS (ESI): 346 (36,
[M+H]+), 305 (100); HRMS (ESI) calcd for C22H36NO2 ([M+H]+):
346.2746; found: 346.2739.
1377m, 11180m, 1032m cmꢀ1 1H NMR (400 MHz, CDCl3): d = 3.95
;
3.89 (m, 1H, CH), 1.86 1.76 (m, 2H, CH2), 1.70 1.57 (m, 3H, CH2),
1.55 1.24 (m, 9H, CH2), 0.83 0.72ppm (m, 12H, CH 3); 13C NMR
(100 MHz, CDCl3): d = 69.6 (CH), 57.3 (C), 56.5 (C), 45.7 (CH2), 34.0
(CH2), 33.5 (CH2), 32.5 (CH2), 32.4 (CH2), 30.8 (CH2), 30.0 (CH2), 8.5
(CH3), 8.2(CH 3), 7.8 (CH3), 7.2ppm (CH 3); MS (ESI): 250 (12,
[M+Na]+), 228 (100, [M+H]+); HRMS (ESI) calcd for C14H30NO
([M+H]+): 228.2327; found: 228.2334.
2,2,7,7-Tetraethylazepan-4-ol-N-oxyl radical (12): To a solution of the
azepanol 11 (151 mg, 0.66 mmol) in MeOH (1.5 mL) and water (0.5 mL)
was added Na2WO4¥2H2O (36 mg, 0.11 mmol) and a 35% aqueous solu-
tion of H2O2 (0.40 mL, 3.96 mmol). The reaction mixture was stirred for
24 h at 258C, quenched with brine, and extracted with MTBE. The organ-
ic layer was dried (MgSO4). Evaporation of the solvents in vacuo yielded
12 (170 mg, 98%) as an orange oil. EPR: aN = 14.09 G.
1
Major isomer: H NMR (500 MHz, CDCl3): d = 7.29 7.25 (m, 4H, CH),
7.23 7.20 (m, 1H, CH), 4.54 (q, J = 6.9 Hz, 1H, CH), 2.79 (dd, J1
=
12.4 Hz, J2 = 7.1 Hz, 2H, CH2), 2.29 0.80 (m, 10H, CH2), 2.14 (s, 2H,
CH2), 1.39 (d, J = 6.9 Hz, 3H, CH3), 1.26 (t, J = 7.1 Hz, 3H, CH3), 0.92
(t, J = 7.6 Hz, 3H, CH3), 0.84 (t, J = 7.6 Hz, 3H, CH3), 0.71 ppm (t, J
= 7.6 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3): d = 208.5 (C), 145.0
(C), 128.0 (2CH), 127.4 (CH), 126.9 (2CH), 82.2 (CH), 71.3 (C), 65.1
(C), 50.2(CH 2), 32.3 (CH2), 31.5 (CH2), 31.1 (CH2), 25.7 (CH2), 24.4
(CH2), 22.7 (CH3), 10.2(CH ), 9.2(CH ), 8.6 (CH3), 8.2ppm (CH 3).
2,2,6,6-Tetraethyl-1-(1-phenylethoxy)piperidin-4-one (13): Nitroxide 6a
(510 mg, 2.23 mmol), Cu dust (142 mg, 2.23 mmol), Cu(OTf)2 (40 mg,
0.11 mmol), (4,4’-di-tert-butyl)-2,2’-bipyridine (60 mg, 0.45 mmol), 1-phe-
nylethylbromide (413 mg, 2.23 mmol), and benzene (7.0 mL) were heated
for 18 h to 758C in a sealed tube under an argon atmosphere. Filtration
over a thin pad of SiO2, washing with MTBE, evaporation of the solvents
in vacuo, and purification by FC (diethyl ether/pentane 1:20) yielded 13
3
3
1
Minor isomer: H NMR (500 MHz, CDCl3): d = 7.29 7.25 (m, 4H, CH),
7.23 7.20 (m, 1H, CH), 4.59 (q, J = 6.7 Hz, 1H, CH), 2.76 (dd, J1
=
(456 mg, 61%). IR (film): n˜
= 3029w, 2971s, 2881m, 1718s, 1464m,
1
1251m, 1060s cmꢀ1; H NMR (400 MHz, CDCl3): d = 7.32 7.24 (m, 5H,
CH), 4.72(q, J = 6.7 Hz, 1H, CH), 2.46 2.26 (brm, 4H, CH2), 2.13 1.98
(brm, 1H, CH2), 1.89 1.55 (brm, 7H, CH2), 1.46 (d, J = 6.7 Hz, 3H,
CH3), 1.15 0.57 ppm (brm, 12H, CH3); 13C NMR (100 MHz, CDCl3): d
12.4 Hz, J2 = 6.9 Hz, 2H, CH2), 2.29 0.80 (m, 10H, CH2), 2.07 (s, 2H,
CH2), 1.38 (d, J = 6.7 Hz, 3H, CH3), 0.95 (t, J = 7.3 Hz, 3H, CH3), 0.92
(t, J = 7.3 Hz, 3H, CH3), 0.67 (t, J = 7.3 Hz, 3H, CH3), 0.66 ppm (t, J
= 7.3 Hz, 3H, CH3); 13C NMR (125 MHz, CDCl3): d = 208.5 (C), 144.9
(C), 128.0 (2CH), 127.2 (CH), 126.6 (2CH), 82.1 (CH), 71.0 (C), 65.9
(C), 50.0 (CH2), 32.2 (CH2), 31.8 (CH2), 31.2(CH 2), 25.4 (CH2), 24.3
(CH2), 23.4 (CH3), 10.0 (CH3), 9.4 (CH3), 8.7 (CH3), 7.3 ppm (CH3).
=
211.0 (C), 145.0 (C), 128.1 (2CH), 127.2 (CH), 126.5 (2CH), 83.1
(CH), 66.2(C), 66.1 (C), 46.7 (CH 2), 31.3 (CH2), 31.0 (CH2), 29.3 (CH2),
29.0 (CH2), 23.5 (CH3), 9.9 (CH3), 9.5 (CH3), 8.6 (CH3), 8.3 ppm (CH3);
MS (ESI): 354 (31, [M+Na]+), 260 (100); HRMS (ESI) calcd for
C21H33NNaO2 ([M+Na]+): 354.2409; found: 354.2393.
2,2,7,7-Tetraethyl-1-(1-phenylethoxy)azepan-4-ol (17): Nitroxide 12
(81 mg, 0.33 mmol), Cu dust (20 mg, 0.32 mmol), Cu(OTf)2 (5.4 mg,
0.015 mmol), (4,4’-di-tert-butyl)-2,2’-bipyridine (8.1 mg, 0.060 mmol), 1-
phenylethylbromide (56 mg, 0.30 mmol), and benzene (1.0 mL) were
heated for 14 h to 758C in a sealed tube under an argon atmosphere. Fil-
tration over a thin pad of SiO2, washing with MTBE, evaporation of the
solvents in vacuo, and purification by FC (MTBE/pentane 1:2) yielded
the alkoxyamine 17 (76 mg, 73%) as a mixture of diastereoisomers
(d.r. = 1.7:1). IR (film): n˜ = 3447br, 2972s, 2879s, 1691w, 1465s, 1373m,
2,2,6,6-Tetraethyl-1-(1-phenylethoxy)piperidin-4-ol (14): Nitroxide
8
(200 mg, 0.88 mmol), Cu dust (54 mg, 0.85 mmol), Cu(OTf)2 (16 mg,
0.044 mmol), (4,4’-di-tert-butyl)-2,2’-bipyridine (24 mg, 0.176 mmol), 1-
phenylethylbromide (154 mg, 0.83 mmol), and benzene (3.0 mL) were
heated for 19 h to 758C in a sealed tube under an argon atmosphere. Fil-
tration over a thin pad of SiO2, washing with MTBE, evaporation of the
solvents in vacuo, and purification by FC (diethyl ether/pentane 1:5)
yielded 14 (83 mg, 30%). IR (film): n˜ = 3440br, 2970s, 2880m, 1727w,
1056s cmꢀ1 13C NMR (100 MHz, CDCl3): d = 146.4 (C), 127.8 (2CH),
;
1537w, 1463m, 1375m cmꢀ1
;
1H NMR (400 MHz, CDCl3): d = 7.33 7.19
126.6 (CH), 125.8 (2CH), 82.3 (CH), 65.4 (C), 65.1 (C), 62.6 (CH), 40.0
(CH2), 39.6 (CH2), 30.1 (CH2), 29.6 (CH2), 29.1 (CH2), 27.3 (CH2), 27.0
(CH2), 24.8 (CH3), 10.1 (CH3), 9.8 (CH3), 8.2(CH 3), 7.9 ppm (CH3); MS
(ESI): 370 (25, [M+Na]+), 348 (19, [M+H]+), 318 (100); HRMS (ESI)
calcd for C22H37NNaO2 ([M+H]+): 370.2722; found: 370.2709.
(m, 5H, CH), 4.68 (q, J = 6.7 Hz, 1H, CH), 3.88 (tt, J1 = 11.4 Hz, J2
=
4.0 Hz, 1H, CH), 2.20 2.10 (m, 1H, CH2), 2.01 1.92 (m, 1H, CH2), 1.81
1.60 (m, 5H, CH2), 1.55 1.24 (m, 3H, CH2), 1.41 (d, J = 6.7 Hz, 3H,
CH3), 1.07 (t, J = 7.3 Hz, 3H, CH3), 0.97 0.75 (m, 2H, CH2), 0.92(t,
J
= 7.7 Hz, 3H, CH3), 0.70 (t, J = 7.5 Hz, 3H, CH3), 0.64 ppm (t, J =
7.1 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3): d = 146.5 (C), 127.9
(2CH), 126.6 (CH), 125.9 (2CH), 82.3 (CH), 65.5 (C), 65.1 (C), 62.7
(CH), 40.0 (CH2), 39.6 (CH2), 30.1 (CH2), 29.1 (CH2), 27.4 (CH2), 27.0
(CH2), 24.9 (CH3), 10.2(CH 3), 9.9 (CH3), 8.2(CH 3), 8.0 ppm (CH3); MS
(ESI): 334 (100, [M+H]+), 318 (86); HRMS (ESI) calcd for C21H36NO2
([M+H]+): 334.2746; found: 334.2740.
1
Major isomer: H NMR (500 MHz, CDCl3): d = 7.30 7.22 (m, 5H, CH),
4.69 4.66 (m, 1H, CH), 3.96 3.88 (m, 1H, CH), 2.34 0.53 ppm (m, 29H).
1
Minor isomer: H NMR (500 MHz, CDCl3): d = 7.30 7.22 (m, 5H, CH),
4.76 4.71 (m, 1H, CH), 4.11 4.05 (m, 1H, CH), 2.34 0.53 ppm (m, 29H).
1,2-Bis(chlorodiethylsilanyl)benzene (23): 1,2-Dibromobenzene (6.58 g,
27.90 mmol) was added dropwise to magnesium turnings (1.40 g,
57.68 mmol) and diethyl chlorosilane (7.12g, 58.01 mmol) in THF
(35 mL). The mixture was heated to reflux for 4 h, and, after cooling to
room temperature, hexane was added (30 mL). The organic layer was
washed with 2n HCl (30 mL) and water (30 mL) and was dried (MgSO4).
Evaporation of the solvents in vacuo and purification by distillation (ꢁ
908C, 1.1 mbar) yielded the bis(diethylsilanyl)benzene (2.04 g, 29%); 1H
NMR (300 MHz): d = 7.83 (dd, J1 = 5.4 Hz, J2 = 3.3 Hz, 2H, CH), 7.60
(dd, J1 = 5.6 Hz, J2 = 3.1 Hz, 2H, CH), 4.37 (qn, J = 3.3 Hz, 2H, SiH),
0.97 0.91 (m, 12H, CH3), 0.90 0.88 ppm (m, 8H, CH2).
2,2-Diethyl-6,6-dimethyl-1-(1-phenylethoxy)piperidin-4-one (15): 2,2-Di-
ethyl-6,6-dimethylpiperidin-4-one-N-oxyl
radical
(6b)
(72mg,
0.363 mmol), Cu dust (22 mg, 0.347 mmol), Cu(OTf)2 (6 mg, 0.017 mmol),
(4,4’-di-tert-butyl)-2,2’-bipyridine (18 mg, 0.066 mmol), 1-phenylethylbro-
mide (61 mg, 0.320 mmol), and benzene (1.2 mL) were heated for 24 h to
758C in a sealed tube under an argon atmosphere. Filtration over a thin
pad of SiO2, washing with MTBE, evaporation of the solvents in vacuo,
and purification by FC (diethyl ether/pentane 1:10) yielded 15 (79 mg,
72%). IR (film): n˜ = 3441w, 2974s, 2938s, 2880m, 1719s, 1494w, 1454m,
1164
¹ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 1156 1166